Database : MEDLINE
Search on : expert and testimony [Words]
References found : 12025 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 1203 go to page                         

  1 / 12025 MEDLINE  
              next record last record
select
to print
Photocopy

[PMID]: 29273569
[Au] Autor:Zeinstra CG; Meuwly D; Ruifrok AC; Veldhuis RN; Spreeuwers LJ
[Ad] Address:Faculty of Electrical Engineering, Mathematics and Computer Science, University of Twente, Enschede, The Netherlands.
[Ti] Title:Forensic face recognition as a means to determine strength of evidence: A survey.
[So] Source:Forensic Sci Rev;30(1):21-32, 2018 Jan.
[Is] ISSN:1042-7201
[Cp] Country of publication:China (Republic : 1949- )
[La] Language:eng
[Ab] Abstract:This paper surveys the literature on forensic face recognition (FFR), with a particular focus on the strength of evidence as used in a court of law. FFR is the use of biometric face recognition for several applications in forensic science. It includes scenarios of ID verification and open-set identification, investigation and intelligence, and evaluation of the strength of evidence. We present FFR from operational, tactical, and strategic perspectives. We discuss criticism of FFR and we provide an overview of research efforts from multiple perspectives that relate to the domain of FFR. Finally, we sketch possible future directions for FFR.
[Mh] MeSH terms primary: Biometric Identification
Face/anatomy & histology
[Mh] MeSH terms secundary: Datasets as Topic
Expert Testimony
Forensic Sciences
Humans
Image Processing, Computer-Assisted
Neural Networks (Computer)
Professional Competence
Research/trends
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1803
[Cu] Class update date: 180308
[Lr] Last revision date:180308
[Js] Journal subset:IM
[Da] Date of entry for processing:171224
[St] Status:MEDLINE

  2 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29231021
[Au] Autor:Wang JJ; Liu C; Liu L; Zhang SY; Li HZ; Cai WX
[Ad] Address:Wenzhou Medical University, Wenzhou 325035, China.
[Ti] Title:[Eye Movement Characteristics of Cooperation Degree during Image Completion Test in Psychiatric Impairment Assessment].
[So] Source:Fa Yi Xue Za Zhi;33(2):154-157, 2017 Apr.
[Is] ISSN:1004-5619
[Cp] Country of publication:China
[La] Language:chi
[Ab] Abstract:OBJECTIVES: To explore the difference of eye movement characteristics between uncooperative and cooperative subjects with mental disorder after cerebral trauma. METHODS: Thirty-nine subjects which needed psychiatric impairment assessment were selected. According to the binomial forced-choice digit memory test (BFDMT), all subjects were divided into cooperative and uncooperative groups. The subjects were asked to take the image completion test from Wechsler adult intelligence scale. Meanwhile, the data of eye movement track, fixation, saccade, pupil and blink were recorded by the track system of eye movement. RESULTS: There were significantly differences ( <0.05) in the data of saccade between cooperative (10 cases) and uncooperative groups (29 cases). The frequency, time, amplitude, acceleration of saccadic in uncooperative group were significantly higher than cooperation group. The saccade latencies of cooperation group increased more than uncooperative group. There was a significant difference ( <0.05) in total discrete distance, average distance and total time of fixation between two groups, while the average duration time, number and frequency of fixation had no significantly difference ( >0.05) between two groups. And the blink frequency of cooperation group was higher than uncooperative group. CONCLUSIONS: Eye movement can be an objective index for the primary judgment of cooperation level.
[Mh] MeSH terms primary: Eye Movements/physiology
Saccades/physiology
[Mh] MeSH terms secundary: Adult
Eye Movement Measurements
Humans
Intelligence Tests
Wechsler Scales
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180308
[Lr] Last revision date:180308
[Js] Journal subset:IM
[Da] Date of entry for processing:171213
[St] Status:MEDLINE
[do] DOI:10.3969/j.issn.1004-5619.2017.02.009

  3 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29342483
[Au] Autor:Marx P
[Ti] Title:Kraftfahreignung nach Schlaganfall. [Fitness to drive after stroke].
[So] Source:Fortschr Neurol Psychiatr;86(1):20-27, 2018 01.
[Is] ISSN:1439-3522
[Cp] Country of publication:Germany
[La] Language:ger
[Ab] Abstract:In Germany, patient information and expert testimony on driving ability requires knowledge of the corresponding legislation and the Guideline for expertises on driver aptitude. The testimony should clearly identify handicaps with regard to driving, give estimates on the future risks of a sudden loss of control, and also consider personal attitudes such as inadequate behavior, lack of insight etc. Physical handicaps often can be compensated for by restrains or restrictions such as vehicle modifications, daylight driving only etc.Both, information and testimony must give estimates on the risks of a sudden loss of control while driving by stroke recurrence or epileptic seizures. In accordance with the Risk-of-Harm-Formula of the Canadian Cardiovascular Society methods are being discussed, by which an estimate of harmful traffic accidents due to stroke recurrence can be calculated.
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1801
[Cu] Class update date: 180305
[Lr] Last revision date:180305
[St] Status:In-Process
[do] DOI:10.1055/s-0043-122393

  4 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29485953
[Au] Autor:Mishuk AU; Qian J; Howard JN; Harris I; Frank G; Kiptanui Z; Hansen R
[Ad] Address:1 Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, Alabama.
[Ti] Title:The Association Between Patient Sociodemographic Characteristics and Generic Drug Use: A Systematic Review and Meta-analysis.
[So] Source:J Manag Care Spec Pharm;24(3):252-264, 2018 Mar.
[Is] ISSN:2376-1032
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:BACKGROUND: Generic drugs are bioequivalent and cost-effective alternatives to brand drugs. In 2014, $254 billion was saved because of the use of generic drugs in the United States. OBJECTIVE: To critically assess evidence on the association between patient characteristics and generic drug use in order to inform the development of educational outreach for improving generic drug use among patients. METHODS: We systematically searched the literature between January 2005 and December 2016 using PubMed, Web of Science, Ovid MEDLINE, Google Scholar, and EBSCO IPA-MEDLINE for potentially relevant studies. The titles and abstracts of identified articles were assessed independently by 2 reviewers. Titles and abstracts that were not written in English, were published before 2005, were not empirical, did not contain sociodemographic data, or were not policy or methodologically relevant to generic drug use were excluded. Data were pooled in a meta-analysis using the RStudio software to assess the association of patient-related factors with generic drug use. RESULTS: Our searches resulted in 11 articles on patient-level factors, and 6 of these articles had sufficient information to conduct meta-analyses in the domains of patients' gender, age, race/ethnicity, and income. Quantitative analysis indicated that no differences in generic drug use existed between subgroups of patients defined by gender, age, or race/ethnicity. However, patients with lower income (i.e., < 200% federal poverty level [FPL]) were more likely to use generic drugs than those with higher income (≥ 200% FPL; pooled OR = 1.32, 95% CI = 1.15-1.52). Heterogeneity was high (I > 75%) for all analyses but income. CONCLUSIONS: Patients with lower income were more likely to use generic drugs, whereas evidence was heterogeneous regarding an association between generic drug use and gender, age, or race/ethnicity. Educational outreach targeting patients with higher incomes to understand their perspectives in generic drugs may help improve generic drug use within that population. DISCLOSURES: Funding for this study was made possible, in part, by the U.S. Food and Drug Administration through grant U01FD005486. Hansen has provided expert testimony for Daiichi Sankyo. No other authors have declared a potential conflict of interest. Views expressed in written materials or publications and by speakers do not necessarily reflect the official policies of the U.S. Department of Health and Human Services, nor does any mention of trade names, commercial practices, or organization imply endorsement by the U.S. government. Study concept and design were contributed by Howard, Harris, Kiptanui, Hansen, and Qian. Frank, Mishuk, Howard, Harris, and Kiptanui collected the data, and data interpretation was performed by Mishuk and Hansen, along with Qian, Harris, and Kiptanui. The manuscript was written and revised primarily by Mishuk, along with Qian and Hansen.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180227
[Lr] Last revision date:180227
[St] Status:In-Process
[do] DOI:10.18553/jmcp.2018.24.3.252

  5 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29468951
[Au] Autor:Santos AS; Guerra-Junior AA; Godman B; Morton A; Ruas CM
[Ad] Address:a Department of Social Pharmacy, College of Pharmacy , Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte , Brazil.
[Ti] Title:Cost-effectiveness thresholds: methods for setting and examples from around the world.
[So] Source:Expert Rev Pharmacoecon Outcomes Res;:1-12, 2018 Feb 27.
[Is] ISSN:1744-8379
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:INTRODUCTION: Cost-effectiveness thresholds (CETs) are used to judge if an intervention represents sufficient value for money to merit adoption in healthcare systems. The study was motivated by the Brazilian context of HTA, where meetings are being conducted to decide on the definition of a threshold. Areas covered: An electronic search was conducted on Medline (via PubMed), Lilacs (via BVS) and ScienceDirect followed by a complementary search of references of included studies, Google Scholar and conference abstracts. Cost-effectiveness thresholds are usually calculated through three different approaches: the willingness-to-pay, representative of welfare economics; the precedent method, based on the value of an already funded technology; and the opportunity cost method, which links the threshold to the volume of health displaced. An explicit threshold has never been formally adopted in most places. Some countries have defined thresholds, with some flexibility to consider other factors. An implicit threshold could be determined by research of funded cases. Expert commentary: CETs have had an important role as a 'bridging concept' between the world of academic research and the 'real world' of healthcare prioritization. The definition of a cost-effectiveness threshold is paramount for the construction of a transparent and efficient Health Technology Assessment system.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180227
[Lr] Last revision date:180227
[St] Status:Publisher
[do] DOI:10.1080/14737167.2018.1443810

  6 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 29478990
[Au] Autor:Pashkov V; Olefir A
[Ad] Address:Poltava Law Institute Of Yaroslav Mudriy National Law University, Poltava, Ukraine.
[Ti] Title:Protection of children's rights in the health care: problems and legal issues.
[So] Source:Wiad Lek;70(6 pt 1):1122-1132, 2017.
[Is] ISSN:0043-5147
[Cp] Country of publication:Poland
[La] Language:eng
[Ab] Abstract:OBJECTIVE: Introduction: Among all categories of patients children (minors) must be protected first. It is caused so by the specificity of the treatment, their vulnerability, the need of further protection and supervision. Providing of medical care services for children are often connected with the risks of the process of treatment, and of the drug usage. The aim: To identify the problems associated with the protection of the rights of minors and, on the basis of this, the basic guarantees of their rights, as well as mark the trends in the practice of ECHR. PATIENTS AND METHODS: Materials and Methods: The study is based on its own theoretical and empirical basis. The theoretical basis include scientific articles, expert reviews of legislation and communications of non-governmental organisations, and empirical - decisions of the ECHR, international legal acts and directives of the EU. RESULTS: Results: The main violations of the rights of minor children include the following: - legal representatives of children do not take to the account their interests (refusal of medical intervention or the choice of certain method of interference); - medical intervention under the influence of coercion; - providing of unwarranted medical care without the corresponding testimony; - providing of inadequate medical care: when the patient was only examined and ineffective treatment was prescribed, and others. As for mentally ill children, the following rights are usually violated: for life, for a fair trial. It has been proved that defects in the provision of health care are often predetermined by the poor state logistics of hospitals, lack of financing and appropriate pediatric medicines, outdated methods of treatment, and incompetence of some doctors. CONCLUSION: Conclusions: From the point of view of protecting the rights of minors, the rights of children in medicine can be classified into universal and special. The rights correspond not only to the corresponding duties of medical staff, but also of their parents (legal representatives). Violations of their rights are usually related to improper representation of the interests of children and disadvantages of providing medical services (defects in their provision), in particular, regarding the treatment of mentally ill, as well as in clinical trials. It has been proven that the practice of the ECHR on the protection of the rights of the child in the field of health is of particular importance.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180226
[Lr] Last revision date:180226
[St] Status:In-Data-Review

  7 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29430713
[Au] Autor:Murigu T; Bhatt N; Miller K; Palmer A; Melegh Z
[Ad] Address:Department of Pathology, Southmead Hospital, Bristol, UK.
[Ti] Title:Spindle cell predominant epithelioid fibrous histiocytoma.
[So] Source:Histopathology;, 2018 Feb 11.
[Is] ISSN:1365-2559
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:No affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. This article is protected by copyright. All rights reserved.
[Pt] Publication type:LETTER
[Em] Entry month:1802
[Cu] Class update date: 180212
[Lr] Last revision date:180212
[St] Status:Publisher
[do] DOI:10.1111/his.13484

  8 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29383056
[Au] Autor:Wolf SJ; Akhtar S; Gross E; Barnes D; Epter M; Fisher J; Moreira M; Smith M; House H
[Ad] Address:University of Virginia School of Medicine, Department of Emergency Medicine, Charlottesville, Virginia.
[Ti] Title:ACGME Clinical and Educational Work Hour Standards: Perspectives and Recommendations from Emergency Medicine Educators.
[So] Source:West J Emerg Med;19(1):49-58, 2018 Jan.
[Is] ISSN:1936-9018
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Introduction: The American College of Emergency Physicians (ACEP) and the Council of Emergency Medicine Residency Directors (CORD) were invited to contribute to the 2016 Accreditation Council for Graduate Medical Education's (ACGME) . We describe the joint process used by ACEP and CORD to capture the opinions of emergency medicine (EM) educators on the ACGME clinical and educational work hour standards, formulate recommendations, and inform subsequent congressional testimony. Methods: In 2016 our joint working group of experts in EM medical education conducted a consensus-based, mixed-methods process using survey data from medical education stakeholders in EM and expert iterative discussions to create organizational position statements and recommendations for revisions of work hour standards. A 19-item survey was administered to a convenience sample of 199 EM residency training programs using a national EM educational listserv. Results: A total of 157 educational leaders responded to the survey; 92 of 157 could be linked to specific programs, yielding a targeted response rate of 46.2% (92/199) of programs. Respondents commented on the impact of clinical and educational work-hour standards on patient safety, programmatic and personnel costs, resident caseload, and educational experience. Using survey results, comments, and iterative discussions, organizational recommendations were crafted and submitted to the ACGME. Conclusion: EM educators believe that ACGME clinical and educational work hour standards negatively impact the learning environment and are not optimal for promoting patient safety or the development of resident professional citizenship.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180202
[Lr] Last revision date:180202
[St] Status:In-Process
[do] DOI:10.5811/westjem.2017.11.35265

  9 / 12025 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29210010
[Au] Autor:Terasaki H; Ogura Y; Kitano S; Sakamoto T; Murata T; Hirakata A; Ishibashi T
[Ad] Address:Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. terasaki@med.nagoya-u.ac.jp.
[Ti] Title:Management of diabetic macular edema in Japan: a review and expert opinion.
[So] Source:Jpn J Ophthalmol;62(1):1-23, 2018 Jan.
[Is] ISSN:1613-2246
[Cp] Country of publication:Japan
[La] Language:eng
[Ab] Abstract:Diabetic retinopathy is a frequent cause of visual impairment in working-age adults (≥30years) and in Japan is most commonly observed in those aged 50-69years. Diabetic macular edema (DME) is one of the main causes of vision disturbance in diabetic retinopathy, which is a clinically significant microvascular complication of diabetes. Anti-vascular endothelial growth factor (VEGF) therapy is becoming the mainstay of treatment for DME. However, to achieve sustained long-term improvement in visual acuity, conventional laser photocoagulation, vitrectomy and steroid therapy are also expected to play a role in the treatment of DME. This review summarizes the epidemiology and pathology of diabetic retinopathy and DME, evaluates the findings regarding the diagnosis and treatment of DME, and underscores the importance of systemic management of the disease in the context of the current health care situation in Japan. Finally, the unmet needs of patients with DME and prospects for research are discussed. The weight of evidence suggests that it is important to establish a multipronged treatment strategy centered on anti-VEGF therapy.
[Mh] MeSH terms primary: Angiogenesis Inhibitors/therapeutic use
Diabetic Retinopathy/therapy
Glucocorticoids/therapeutic use
Laser Coagulation
Macular Edema/therapy
Vitrectomy
[Mh] MeSH terms secundary: Combined Modality Therapy
Diabetic Retinopathy/diagnosis
Expert Testimony
Humans
Macular Edema/diagnosis
Vascular Endothelial Growth Factor A/antagonists & inhibitors
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:0 (Angiogenesis Inhibitors); 0 (Glucocorticoids); 0 (VEGFA protein, human); 0 (Vascular Endothelial Growth Factor A)
[Em] Entry month:1801
[Cu] Class update date: 180119
[Lr] Last revision date:180119
[Js] Journal subset:IM
[Da] Date of entry for processing:171207
[St] Status:MEDLINE
[do] DOI:10.1007/s10384-017-0537-6

  10 / 12025 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 29303714
[Au] Autor:Nordstrm A
[Ad] Address:UN Policy Department, Ministry for Foreign Affairs, Government of Sweden, S-103 33 Stockholm, Sweden. Electronic address: anders.nordstrom@gov.se.
[Ti] Title:Is WHO ready to improve its country work?
[So] Source:Lancet;390(10114):2749-2751, 2018 12 23.
[Is] ISSN:1474-547X
[Cp] Country of publication:England
[La] Language:eng
[Mh] MeSH terms primary: Global Health
Health Priorities
World Health Organization/organization & administration
[Mh] MeSH terms secundary: Expert Testimony
Humans
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1801
[Cu] Class update date: 180117
[Lr] Last revision date:180117
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180106
[St] Status:MEDLINE


page 1 of 1203 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information